Purdue Pharma reaches new $5.5bn-$6bn settlement in bankruptcy case
  • X
  • LinkedIn
  • Show more sharing options
  • Print
  • X
  • LinkedIn
  • Free Trial
  • Log in

Purdue Pharma reaches new $5.5bn-$6bn settlement in bankruptcy case

Jairo Ibarra
March 03, 2022
  • X
  • LinkedIn
  • Show more sharing options
  • Print
  • X
  • LinkedIn
Prescription drug pill bottle oxycodene.jpg

Purdue Pharma has reached a new settlement with the nine states opposing its latest Chapter 11 plan that would raise the Sackler family’s contributions to as much as $6bn.

The new settlement comes after the court last month ordered the nine states and the Sackler family mediation parties back to negotiations around the proposed Chapter 11 plan, which had faced objections, according to court documents reviewed by Inside...

Request a free trial:

Fuel a smarter strategy with our actionable market intelligence

    • Gain a competitive edge and accelerate decision-making
    • Be empowered by insights that transform confusion to clarity
    • Uncover growth opportunities and prepare for potential threats
Request a free trial Already a subscriber? Log in now

Topics

NewsLegal
jairo ibarra/jairo ibarra ii us.png
Jairo Ibarra
Senior Reporter
Contact
Gift this article